002166 莱茵生物
已收盘 08-20 15:00:00
资讯
新帖
简况
莱茵生物：关于公司董事辞职的公告
新浪财经-鹰眼工作室 · 08-19 19:00
莱茵生物：关于公司董事辞职的公告
莱茵生物最新公告：控股孙公司利川华恒收到环保部门行政处罚决定书
证券之星 · 08-15
莱茵生物最新公告：控股孙公司利川华恒收到环保部门行政处罚决定书
莱茵生物：8月13日高管姚新德减持股份合计217.08万股
证券之星 · 08-14
莱茵生物：8月13日高管姚新德减持股份合计217.08万股
莱茵生物（002166）8月13日主力资金净卖出1633.21万元
证券之星 · 08-14
莱茵生物（002166）8月13日主力资金净卖出1633.21万元
莱茵生物：8月9日高管姚新德减持股份合计85万股
证券之星 · 08-12
莱茵生物：8月9日高管姚新德减持股份合计85万股
莱茵生物（002166）8月7日主力资金净卖出1400.17万元
证券之星 · 08-08
莱茵生物（002166）8月7日主力资金净卖出1400.17万元
莱茵生物：其股价涨跌只会影响公司非经常损益，不会对公司营业收入产生影响
证券之星 · 08-07
莱茵生物：其股价涨跌只会影响公司非经常损益，不会对公司营业收入产生影响
莱茵生物新提交5件商标注册申请
证券之星 · 08-05
莱茵生物新提交5件商标注册申请
莱茵生物新提交3件商标注册申请
证券之星 · 07-12
莱茵生物新提交3件商标注册申请
莱茵生物：7月10日高管姚新德减持股份合计20.86万股
证券之星 · 07-11
莱茵生物：7月10日高管姚新德减持股份合计20.86万股
天风证券7月11日发布研报称，给予莱茵生物（002166.SZ）买入评级。评级理由主要包括：1）植提业务持续向好，24H1公司盈利能力不断增强；
智通财经 · 07-11
天风证券7月11日发布研报称，给予莱茵生物（002166.SZ）买入评级。评级理由主要包括：1）植提业务持续向好，24H1公司盈利能力不断增强；
代糖(甜味剂)概念盘中拉升，莱茵生物涨1.66%
自选股智能写手 · 07-09
代糖(甜味剂)概念盘中拉升，莱茵生物涨1.66%
【莱茵生物(002166.SZ)发预增，预计上半年净利润5429.46万元–6515.36万元 增长50%—80%】智通财经APP讯，莱茵生物(002166.
智通财经 · 07-08
【莱茵生物(002166.SZ)发预增，预计上半年净利润5429.46万元–6515.36万元 增长50%—80%】智通财经APP讯，莱茵生物(002166.
莱茵生物(002166.SZ)发预增，预计上半年净利润5429.46万元–6515.36万元 增长50%—80%
智通财经 · 07-08
莱茵生物(002166.SZ)发预增，预计上半年净利润5429.46万元–6515.36万元 增长50%—80%
莱茵生物公告，预计2024年上半年实现净利润5429.46万元至6515.36万元，比上年同期增长50%至80%。报告期内，公司所处的植物提取行业持续向好发展，受益于市场需求带动和自身经营能力的提升，公司营业收入较去年同期大幅增长，主营业务毛利率实现了较好的回升，业务盈利能力不断增强。
华尔街见闻 · 07-08
莱茵生物公告，预计2024年上半年实现净利润5429.46万元至6515.36万元，比上年同期增长50%至80%。报告期内，公司所处的植物提取行业持续向好发展，受益于市场需求带动和自身经营能力的提升，公司营业收入较去年同期大幅增长，主营业务毛利率实现了较好的回升，业务盈利能力不断增强。
莱茵生物：预计2024年1-6月归属净利润盈利5429.46万元至6515.36万元
证券之星 · 07-08
莱茵生物：预计2024年1-6月归属净利润盈利5429.46万元至6515.36万元
莱茵生物最新公告：预计上半年净利同比增长50%-80%
证券之星 · 07-08
莱茵生物最新公告：预计上半年净利同比增长50%-80%
莱茵生物：预计上半年净利同比增长50%-80%莱茵生物公告，预计2024年半年度净利润5429.46万元–6515.36万元，同比增长50%–80%。
格隆汇 · 07-08
莱茵生物：预计上半年净利同比增长50%-80%莱茵生物公告，预计2024年半年度净利润5429.46万元–6515.36万元，同比增长50%–80%。
莱茵生物：7月2日高管姚新德减持股份合计43.57万股
证券之星 · 07-03
莱茵生物：7月2日高管姚新德减持股份合计43.57万股
莱茵生物最新公告：公司董事、高管拟合计减持不超0.94%股份
证券之星 · 06-06
莱茵生物最新公告：公司董事、高管拟合计减持不超0.94%股份
暂无数据
公司概况
公司名称：
桂林莱茵生物科技股份有限公司
所属行业：
医药制造业
上市日期：
2007-09-13
主营业务：
桂林莱茵生物科技股份有限公司主要从事天然健康产品业务,主要产品是罗汉果提取物、甜叶菊提取物、工业大麻提取物、茶叶提取物及其他保健护肤提取物。公司先后获得“植物提取物优质供应商”、“中国质量诚信企业”、“中国农业企业500强”等殊荣，2023年顺利通过“国家级专精特新小巨人企业”、“农业产业化国家重点龙头企业”等荣誉复审，作为植物提取行业绿色转型升级的示范标杆企业更是取得了“国家级绿色工厂”的荣誉称号。
发行价格：
9.89
{"stockData":{"symbol":"002166","market":"SZ","secType":"STK","nameCN":"莱茵生物","latestPrice":6.76,"timestamp":1724137389000,"preClose":6.85,"halted":0,"volume":7864606,"delay":0,"floatShares":513999999,"shares":742000000,"eps":0.1205,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.09,"latestTime":"08-20 15:00:00","open":6.81,"high":6.88,"low":6.71,"amount":53287700,"amplitude":0.0248,"askPrice":6.76,"askSize":79,"bidPrice":6.75,"bidSize":477,"shortable":0,"etf":0,"ttmEps":0.1205,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1724203800000},"adr":0,"adjPreClose":6.85,"symbolType":"stock","openAndCloseTimeList":[[1724117400000,1724124600000],[1724130000000,1724137200000]],"highLimit":7.54,"lowLimit":6.17,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":741986825,"pbRate":1.63,"roa":"--","roe":"0.86%","epsLYR":0.11,"committee":0.588561,"marketValue":5016000000,"floatMarketCap":3471000000,"peRate":56.099586,"changeRate":-0.0131,"turnoverRate":0.0153,"status":1},"requestUrl":"/m/hq/s/002166/tweets","defaultTab":"tweets","newsList":[{"id":"2460208235","title":"莱茵生物：关于公司董事辞职的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2460208235","media":"新浪财经-鹰眼工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460208235?lang=zh_cn&edition=full","pubTime":"2024-08-19 19:00","pubTimestamp":1724065200,"startTime":"0","endTime":"0","summary":"桂林莱茵生物科技股份有限公司董事会于2024年8月19日收到公司董事姚新德先生递交的书面辞职报告。姚新德先生因个人原因，申请辞去公司第六届董事会董事及薪酬与考核委员会委员职务。桂林莱茵生物科技股份有限公司董事会二〇二四年八月二十日","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/ggzz/2024-08-19/doc-incketiy4359354.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2024-08-19/doc-incketiy4359354.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0168","BK0028","BK0174","BK0239","BK0046","002166"],"gpt_icon":0},{"id":"2459426375","title":"莱茵生物最新公告：控股孙公司利川华恒收到环保部门行政处罚决定书","url":"https://stock-news.laohu8.com/highlight/detail?id=2459426375","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459426375?lang=zh_cn&edition=full","pubTime":"2024-08-15 20:09","pubTimestamp":1723723794,"startTime":"0","endTime":"0","summary":"莱茵生物公告，控股孙公司利川华恒收到环保部门行政处罚决定书，因在生产工艺流程中存在生态环境违法行为，利川华恒被恩施州生态环境局处以罚款60.15万元。本次行政处罚不会对公司及控股孙公司利川华恒的生产经营活动造成重大影响。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081500041334.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0168","BK0028","BK0174","BK0239","BK0046","002166"],"gpt_icon":0},{"id":"2459179727","title":"莱茵生物：8月13日高管姚新德减持股份合计217.08万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2459179727","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459179727?lang=zh_cn&edition=full","pubTime":"2024-08-14 21:01","pubTimestamp":1723640469,"startTime":"0","endTime":"0","summary":"证券之星消息，根据8月14日市场公开信息、上市公司公告及交易所披露数据整理，莱茵生物最新董监高及相关人员股份变动情况：2024年8月13日公司董事姚新德共减持公司股份217.08万股，占公司总股本为0.2926%。莱茵生物近半年内的董监高及核心技术人员增减持详情如下：莱茵生物的高管列表及最新持股情况如下：融资融券数据显示该股近5日融资净流入516.67万，融资余额增加；融券净流入800.0，融券余额增加。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081400044567.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0168","BK0046","BK0028","002166","BK0239","BK0174"],"gpt_icon":0},{"id":"2459169790","title":"莱茵生物（002166）8月13日主力资金净卖出1633.21万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459169790","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459169790?lang=zh_cn&edition=full","pubTime":"2024-08-14 09:23","pubTimestamp":1723598588,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年8月13日收盘，莱茵生物报收于6.85元，下跌2.42%，换手率3.14%，成交量16.12万手，成交额1.1亿元。近5日资金流向一览见下表：莱茵生物融资融券信息显示，融资方面，当日融资买入1187.47万元，融资偿还738.93万元，融资净买入448.54万元。莱茵生物主营业务：天然健康产品的生产经营业务,持续专注植物功能性成分提取领域。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081400016526.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0168","BK0028","BK0174","BK0046","002166","BK0239"],"gpt_icon":0},{"id":"2458988691","title":"莱茵生物：8月9日高管姚新德减持股份合计85万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2458988691","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458988691?lang=zh_cn&edition=full","pubTime":"2024-08-12 21:01","pubTimestamp":1723467664,"startTime":"0","endTime":"0","summary":"证券之星消息，根据8月12日市场公开信息、上市公司公告及交易所披露数据整理，莱茵生物最新董监高及相关人员股份变动情况：2024年8月9日公司董事姚新德共减持公司股份85.0万股，占公司总股本为0.1146%。莱茵生物近半年内的董监高及核心技术人员增减持详情如下：莱茵生物的高管列表及最新持股情况如下：融资融券数据显示该股近5日融资净流入582.56万，融资余额增加；融券净流入1200.0，融券余额增加。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081200031322.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0168","BK0046","BK0174","BK0239","002166"],"gpt_icon":0},{"id":"2457847233","title":"莱茵生物（002166）8月7日主力资金净卖出1400.17万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457847233","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457847233?lang=zh_cn&edition=full","pubTime":"2024-08-08 09:47","pubTimestamp":1723081663,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年8月7日收盘，莱茵生物报收于7.03元，下跌2.36%，换手率2.45%，成交量12.58万手，成交额8880.53万元。近5日资金流向一览见下表：莱茵生物融资融券信息显示，融资方面，当日融资买入705.48万元，融资偿还447.5万元，融资净买入257.98万元。莱茵生物主营业务：天然健康产品的生产经营业务,持续专注植物功能性成分提取领域。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080800014470.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0174","BK0168","BK0028","002166","BK0046"],"gpt_icon":0},{"id":"2457818090","title":"莱茵生物：其股价涨跌只会影响公司非经常损益，不会对公司营业收入产生影响","url":"https://stock-news.laohu8.com/highlight/detail?id=2457818090","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457818090?lang=zh_cn&edition=full","pubTime":"2024-08-07 18:02","pubTimestamp":1723024935,"startTime":"0","endTime":"0","summary":"证券之星消息，莱茵生物08月07日在投资者关系平台上答复投资者关心的问题。投资者：董秘你好，公司茶叶提取物产品主要是子公司华高生物在做，2023年营收披露约1.8亿，请问其中茶多酚占比大概多少？","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080700037782.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002166"],"gpt_icon":0},{"id":"2457414797","title":"莱茵生物新提交5件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2457414797","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457414797?lang=zh_cn&edition=full","pubTime":"2024-08-05 13:25","pubTimestamp":1722835517,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示，近日桂林莱茵生物科技股份有限公司新提交5件商标注册申请。商标申请详情如下：今年以来桂林莱茵生物科技股份有限公司新申请注册商标29件，截止目前公司共持有注册商标398件，另有58件商标尚在注册申请中。数据来源：企查查以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080500012511.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002166","BK0046","BK0174","BK0028","BK0168"],"gpt_icon":0},{"id":"2450273843","title":"莱茵生物新提交3件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2450273843","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450273843?lang=zh_cn&edition=full","pubTime":"2024-07-12 13:04","pubTimestamp":1720760654,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示，近日桂林莱茵生物科技股份有限公司新提交3件商标注册申请。商标申请详情如下：今年以来桂林莱茵生物科技股份有限公司新申请注册商标13件，截止目前公司共持有注册商标398件，另有42件商标尚在注册申请中。数据来源：企查查以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071200023229.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0028","002166","BK0174","BK0168","BK0239"],"gpt_icon":0},{"id":"2450357669","title":"莱茵生物：7月10日高管姚新德减持股份合计20.86万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2450357669","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450357669?lang=zh_cn&edition=full","pubTime":"2024-07-11 21:00","pubTimestamp":1720702852,"startTime":"0","endTime":"0","summary":"证券之星消息，根据7月11日市场公开信息、上市公司公告及交易所披露数据整理，莱茵生物最新董监高及相关人员股份变动情况：2024年7月10日公司董事姚新德共减持公司股份20.86万股，占公司总股本为0.0281%。莱茵生物近半年内的董监高及核心技术人员增减持详情如下：莱茵生物的高管列表及最新持股情况如下：融资融券数据显示该股近5日融资净流出333.28万，融资余额减少；融券净流出1600.0，融券余额减少。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071100041262.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002166","BK0168","BK0174","BK0046","BK0028"],"gpt_icon":0},{"id":"2450337320","title":"天风证券7月11日发布研报称，给予莱茵生物（002166.SZ）买入评级。评级理由主要包括：1）植提业务持续向好，24H1公司盈利能力不断增强；","url":"https://stock-news.laohu8.com/highlight/detail?id=2450337320","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450337320?lang=zh_cn&edition=full","pubTime":"2024-07-11 18:36","pubTimestamp":1720694180,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK0276","BK0028","002166","BK0239","BK0046","BK0174","BK0168","601162"],"gpt_icon":0},{"id":"2450552910","title":"代糖(甜味剂)概念盘中拉升，莱茵生物涨1.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450552910","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450552910?lang=zh_cn&edition=full","pubTime":"2024-07-09 09:46","pubTimestamp":1720489596,"startTime":"0","endTime":"0","summary":"07月09日，代糖(甜味剂)概念盘中拉升，截至09点46分，代糖(甜味剂)概念整体指数上涨0.52%，报753.240点。从个股上来看，该概念的成分股中，莱茵生物涨1.66%，鲁信创投、三元生物、华康股份涨幅居前。从资金上来看，截止发稿，代糖(甜味剂)概念主力净流入为-687.36万，其中鲁信创投受到资金热捧，主力净流入144.63万；拉长时间线来看，该板块近20日主力资金净流入-3.41亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709094636941f51aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709094636941f51aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","BK0075","600783","BK0046","BK0276","BK0028","BK0188","002166","BK0174","BK0168","BK0059"],"gpt_icon":0},{"id":"2449688778","title":"【莱茵生物(002166.SZ)发预增，预计上半年净利润5429.46万元–6515.36万元 增长50%—80%】智通财经APP讯，莱茵生物(002166.","url":"https://stock-news.laohu8.com/highlight/detail?id=2449688778","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449688778?lang=zh_cn&edition=full","pubTime":"2024-07-08 18:37","pubTimestamp":1720435027,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK0239","002166","BK0046","BK0174","BK0028","BK0168"],"gpt_icon":0},{"id":"2449524778","title":"莱茵生物(002166.SZ)发预增，预计上半年净利润5429.46万元–6515.36万元 增长50%—80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449524778","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449524778?lang=zh_cn&edition=full","pubTime":"2024-07-08 18:37","pubTimestamp":1720435027,"startTime":"0","endTime":"0","summary":"智通财经APP讯，莱茵生物 发布2024年半年度业绩预告，预计上半年归属于上市公司股东的净利润5429.46万元–6515.36万元，同比增长50%—80%。净利润方面，受益于营收增长、毛利率提升及股份支付成本减少等因素，报告期内公司利润大幅提升，预计公司半年度归属于上市公司股东的净利润将同比增长50%–80%。同时，由于公司主营业务利润的占比大幅提升，预计报告期扣除非经常性损益后的净利润较上年同期增长约1041.73%—1315.69%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1147109.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002166"],"gpt_icon":0},{"id":"2449576720","title":"莱茵生物公告，预计2024年上半年实现净利润5429.46万元至6515.36万元，比上年同期增长50%至80%。报告期内，公司所处的植物提取行业持续向好发展，受益于市场需求带动和自身经营能力的提升，公司营业收入较去年同期大幅增长，主营业务毛利率实现了较好的回升，业务盈利能力不断增强。","url":"https://stock-news.laohu8.com/highlight/detail?id=2449576720","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449576720?lang=zh_cn&edition=full","pubTime":"2024-07-08 18:20","pubTimestamp":1720434033,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/a-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/a-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["BK0239","BK0174","BK0168","BK0028","002166","BK0046"],"gpt_icon":0},{"id":"2449727741","title":"莱茵生物：预计2024年1-6月归属净利润盈利5429.46万元至6515.36万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449727741","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449727741?lang=zh_cn&edition=full","pubTime":"2024-07-08 18:02","pubTimestamp":1720432939,"startTime":"0","endTime":"0","summary":"证券之星消息，莱茵生物发布业绩预告，预计2024年1-6月归属净利润盈利5429.46万元至6515.36万元。同时，由于公司主营业务桂林莱茵生物科技股份有限公司利润的占比大幅提升，预计报告期扣除非经常性损益后的净利润较上年同期增长约 1041.73%—1315.69%。莱茵生物2024年一季报显示，公司主营收入3.41亿元，同比上升35.07%；归母净利润2679.01万元，同比上升34.37%；扣非净利润3957.09万元，同比上升372.05%；负债率33.19%，财务费用345.99万元，毛利率26.05%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070800024970.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002166"],"gpt_icon":0},{"id":"2449276537","title":"莱茵生物最新公告：预计上半年净利同比增长50%-80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449276537","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449276537?lang=zh_cn&edition=full","pubTime":"2024-07-08 18:00","pubTimestamp":1720432857,"startTime":"0","endTime":"0","summary":"莱茵生物公告，预计2024年半年度净利润5429.46万元–6515.36万元，同比增长50%–80%。受益于营收增长、毛利率提升及股份支付成本减少等因素，报告期内公司利润大幅提升。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070800024699.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002166","BK0046","BK0174","BK0028","BK0168"],"gpt_icon":0},{"id":"2449722540","title":"莱茵生物：预计上半年净利同比增长50%-80%莱茵生物公告，预计2024年半年度净利润5429.46万元–6515.36万元，同比增长50%–80%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2449722540","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449722540?lang=zh_cn&edition=full","pubTime":"2024-07-08 17:52","pubTimestamp":1720432324,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0028","002166","BK0239","BK0046","BK0168","BK0174"],"gpt_icon":0},{"id":"2448100934","title":"莱茵生物：7月2日高管姚新德减持股份合计43.57万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2448100934","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448100934?lang=zh_cn&edition=full","pubTime":"2024-07-03 21:06","pubTimestamp":1720011981,"startTime":"0","endTime":"0","summary":"证券之星消息，根据7月3日市场公开信息、上市公司公告及交易所披露数据整理，莱茵生物最新董监高及相关人员股份变动情况：2024年7月2日公司董事姚新德共减持公司股份43.57万股，占公司总股本为0.0587%。莱茵生物近半年内的董监高及核心技术人员增减持详情如下：莱茵生物的高管列表及最新持股情况如下：融资融券数据显示该股近5日融资净流出44.17万，融资余额减少；融券净流入8000.0，融券余额增加。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070300045571.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0028","002166","BK0174","BK0168","BK0239"],"gpt_icon":0},{"id":"2441671139","title":"莱茵生物最新公告：公司董事、高管拟合计减持不超0.94%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2441671139","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2441671139?lang=zh_cn&edition=full","pubTime":"2024-06-06 20:41","pubTimestamp":1717677713,"startTime":"0","endTime":"0","summary":"莱茵生物公告，公司董事姚新德，董事、常务副总经理谢永富，董事、副总经理白昱，副总经理、董事会秘书罗华阳，财务总监郑辉计划在公告披露之日起15个交易日后3个月内，以集中竞价交易方式和大宗交易方式合计减持不超过0.94%股份。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024060600042587.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0174","BK0168","BK0028","002166","BK0046"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2007-09-13","address":"广西壮族自治区桂林市临桂区人民南路19号","stockEarnings":[{"period":"1week","weight":-0.0131},{"period":"1month","weight":-0.0273},{"period":"3month","weight":-0.1619},{"period":"6month","weight":0.0325},{"period":"1year","weight":-0.0362},{"period":"ytd","weight":-0.1069}],"companyName":"桂林莱茵生物科技股份有限公司","boardCode":"AI0027","perCapita":"9666股","boardName":"医药制造业","registeredCapital":"74198万元","compareEarnings":[{"period":"1week","weight":-0.0004},{"period":"1month","weight":-0.0388},{"period":"3month","weight":-0.0924},{"period":"6month","weight":-0.0407},{"period":"1year","weight":-0.0732},{"period":"ytd","weight":-0.0364}],"survey":" 桂林莱茵生物科技股份有限公司主要从事天然健康产品业务,主要产品是罗汉果提取物、甜叶菊提取物、工业大麻提取物、茶叶提取物及其他保健护肤提取物。公司先后获得“植物提取物优质供应商”、“中国质量诚信企业”、“中国农业企业500强”等殊荣，2023年顺利通过“国家级专精特新小巨人企业”、“农业产业化国家重点龙头企业”等荣誉复审，作为植物提取行业绿色转型升级的示范标杆企业更是取得了“国家级绿色工厂”的荣誉称号。","serverTime":1724179034147,"listedPrice":9.89,"stockholders":"53122人(较上一季度增加0.22%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"莱茵生物(002166)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供莱茵生物(002166)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"莱茵生物,002166,莱茵生物股票,莱茵生物股票老虎,莱茵生物股票老虎国际,莱茵生物行情,莱茵生物股票行情,莱茵生物股价,莱茵生物股市,莱茵生物股票价格,莱茵生物股票交易,莱茵生物股票购买,莱茵生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"莱茵生物(002166)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供莱茵生物(002166)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}